silhouette form of bull on technical financial graph 3d illustration


Funding Overview

Cambridge, Massachusetts-based Agios Prescription drugs (NASDAQ:AGIO) accomplished its Preliminary Public Providing over a decade in the past in July 2013, elevating ~$106m through the issuance of ~5.9m shares priced at $18 per share.

The corporate developed and efficiently received approval


Source link